Phreesia, Inc. (NYSE:PHR) COO Sells $172,507.05 in Stock

Phreesia, Inc. (NYSE:PHR) COO Evan Roberts sold 7,233 shares of the firm’s stock in a transaction on Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $172,507.05. Following the completion of the transaction, the chief operating officer now owns 776,652 shares in the company, valued at $18,523,150.20. The trade was a 0.92 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Evan Roberts also recently made the following trade(s):

• On Tuesday, February 18th, Evan Roberts sold 3,519 shares of Phreesia stock. The stock was sold at an average price of $30.06, for a total transaction of $105,781.14.
• On Thursday, February 13th, Evan Roberts sold 16,005 shares of Phreesia stock. The stock was sold at an average price of $30.00, for a total transaction of $480,150.00.
• On Monday, January 27th, Evan Roberts sold 10,716 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $294,475.68.
• On Tuesday, January 21st, Evan Roberts sold 12,749 shares of Phreesia stock. The stock was sold at an average price of $27.31, for a total value of $348,175.19.
• On Wednesday, January 15th, Evan Roberts sold 1,785 shares of Phreesia stock. The shares were sold at an average price of $26.98, for a total value of $48,159.30.

Phreesia Price Performance

Shares of NYSE:PHR opened at $24.09 on Friday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.74 and a current ratio of 1.74. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The firm has a market cap of $1.42 billion, a PE ratio of -16.39 and a beta of 0.82. The firm’s fifty day moving average is $26.66 and its 200-day moving average is $24.25.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of PHR. Johnson Financial Group Inc. increased its stake in shares of Phreesia by 381.3% in the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company’s stock valued at $28,000 after buying an additional 896 shares during the period. R Squared Ltd acquired a new stake in Phreesia during the 4th quarter valued at approximately $30,000. BankPlus Trust Department bought a new position in Phreesia during the 4th quarter worth approximately $34,000. Quarry LP lifted its position in shares of Phreesia by 210.9% in the 4th quarter. Quarry LP now owns 2,835 shares of the company’s stock worth $71,000 after purchasing an additional 1,923 shares during the period. Finally, Venturi Wealth Management LLC bought a new stake in shares of Phreesia in the 4th quarter valued at $76,000. 92.10% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Citigroup raised their price objective on Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research note on Friday, January 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the stock from $24.00 to $32.00 in a report on Wednesday, January 8th. KeyCorp lifted their price target on shares of Phreesia from $28.00 to $30.00 and gave the company an “overweight” rating in a report on Wednesday, January 8th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research note on Thursday, March 13th. Finally, Canaccord Genuity Group boosted their target price on shares of Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, March 13th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.